[REVISION HISTORY]
DEA fentanyl controversy deepens with DOJ and House probes
5 recorded revisions of this situation.
What changed
2026-09-01 01:56 UTC → 2026-09-01 20:56 UTC ·
added
removed
New Mexico officials have intensified legal and political action after whistleblowers alleged that DEA agents allowed more than one million counterfeit fentanyl pills to circulate in the state between 2023 and 2025 while building larger cases. The claim, made by Special Agent David Howell and attorney Tristan Leavitt, echoes earlier accusations that the agency ignored the 2019 seizure mandate and monitored shipments instead. Overdose deaths rose 21% during that period, prompting Governor Michelle Lujan Grisham to announce a bid for billions of dollars in civil damages and to demand full documentation of every declined seizure since Jan. 17. Attorney General Raúl Torrez opened a criminal investigation, seeking records, possible prosecutions and reforms. The Biden-era Justice Department revised its fentanyl-seizure guidelines in July 2026, granting agents discretion rather than a mandatory seizure requirement. The federal Office of the Inspector General and the DOJ’s own OIG have launched parallel probes, including a 20-page complaint from a third unnamed DEA special agent describing multiple large fentanyl and methamphetamine deliveries that were tracked rather than seized. In August 2026, DOJ Inspector General Don Berthiaume announced a formal review of the tactic, which some describe as allowing drugs to ‘walk.’ The investigation will examine whether agents monitored deliveries to avoid jeopardizing major prosecutions. One internal report highlighted a specific instance in Albuquerque where the DEA declined to interdict a delivery of 74,000 fentanyl pills. Concurrently, House Republicans on the Oversight Committee have launched an investigation into the DEA, with DEA. Chairman James Comer requesting has requested records from Attorney General Todd Blanche. Comer is examining Blanche to examine whether the administration disregarded risk mitigation protocols from the previous administration, following allegations that agents were ordered instructed to ‘stand down’ rather than intercept shipments. Comer characterized a policy directing agents not to intercept significant shipments as ‘unconscionable,’ noting it has likely resulted in considerable harm and loss of life. In a parallel legal action, Attorney General Raúl Torrez has sued the Department of Justice to compel the release of similar records.
Versions
- 2026-09-01 20:56 UTC DEA fentanyl controversy deepens with DOJ and House probes
- 2026-09-01 01:56 UTC DEA fentanyl controversy deepens with DOJ and House probes
- 2026-08-31 15:40 UTC DEA fentanyl controversy deepens with DOJ and House probes
- 2026-08-17 17:24 UTC DEA fentanyl controversy deepens with DOJ probe
- 2026-08-17 17:24 UTC DEA fentanyl controversy deepens with DOJ probe
- 2026-08-05 00:18 UTC DEA fentanyl controversy deepens with DOJ probe
Select a version to see what changed compared to the one before it.